Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Bioorganic & Medicinal Chemistry
|
June 24, 2008
Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives
Dahui Zhou, Ping Zhou, Deborah A Evrard, et al.
Journal of Medicinal Chemistry
|
October 12, 2010
5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists
Kevin G Liu, Albert J Robichaud, Ronald C Bernotas, et al.
Journal of Medicinal Chemistry
|
September 5, 2019
Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity
Lei Zhang, Christopher R Butler, Kevin P Maresca, et al.
Journal of Medicinal Chemistry
|
July 21, 2006
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity
Nicole T Hatzenbuhler, Deborah A Evrard, Boyd L Harrison, et al.
Bioorganic & Medicinal Chemistry
|
November 25, 2010
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists
Kevin G Liu, Albert J Robichaud, Alexander A Greenfield, et al.
Journal of Medicinal Chemistry
|
May 13, 2005
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan
Wayne E Childers, Magid A Abou-Gharbia, Michael G Kelly, et al.
Journal of Medicinal Chemistry
|
October 7, 2008
Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2
Nicole T Hatzenbuhler, Reinhardt Baudy, Deborah A Evrard, et al.
Journal of Medicinal Chemistry
|
October 24, 2007
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist
Derek C Cole, Joseph R Stock, William J Lennox, et al.
Journal of Medicinal Chemistry
|
September 2, 2009
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists
Dahui Zhou, Gary P Stack, Jennifer Lo, et al.
The International Journal of Neuropsychopharmacology
|
January 6, 2010
Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism
Jason M Dwyer, Brian J Platt, Stacey J Sukoff Rizzo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Bioorganic & Medicinal Chemistry
|
June 24, 2008
Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives
Dahui Zhou, Ping Zhou, Deborah A Evrard, et al.
Journal of Medicinal Chemistry
|
October 12, 2010
5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists
Kevin G Liu, Albert J Robichaud, Ronald C Bernotas, et al.
Journal of Medicinal Chemistry
|
September 5, 2019
Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity
Lei Zhang, Christopher R Butler, Kevin P Maresca, et al.
Journal of Medicinal Chemistry
|
July 21, 2006
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity
Nicole T Hatzenbuhler, Deborah A Evrard, Boyd L Harrison, et al.
Bioorganic & Medicinal Chemistry
|
November 25, 2010
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists
Kevin G Liu, Albert J Robichaud, Alexander A Greenfield, et al.
Journal of Medicinal Chemistry
|
May 13, 2005
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan
Wayne E Childers, Magid A Abou-Gharbia, Michael G Kelly, et al.
Journal of Medicinal Chemistry
|
October 7, 2008
Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2
Nicole T Hatzenbuhler, Reinhardt Baudy, Deborah A Evrard, et al.
Journal of Medicinal Chemistry
|
October 24, 2007
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist
Derek C Cole, Joseph R Stock, William J Lennox, et al.
Journal of Medicinal Chemistry
|
September 2, 2009
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists
Dahui Zhou, Gary P Stack, Jennifer Lo, et al.
The International Journal of Neuropsychopharmacology
|
January 6, 2010
Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism
Jason M Dwyer, Brian J Platt, Stacey J Sukoff Rizzo, et al.
Page
of 5